Table 1 Patient demographics and pathological stage.

From: Computer-Aided Nodule Assessment and Risk Yield (CANARY) may facilitate non-invasive prediction of EGFR mutation status in lung adenocarcinomas

Demographics

n = 118

Age at diagnosis: median years (range)

68 (35–91)

Gender n (%)

 Women

65 (55%)

 Men

53 (45%)

Smoking n (%)

 Current

27 (23%)

 Former

77 (65%)

 Never

14 (12%)

Pathologic TNM stage n (%)

 I

94 (80%)

 II

12 (10%)

 III

11 (9%)

 IV

1 (1%)